Table 1.
Prevalence of Wave 1 Past 30-day Cigarette and E-cigarette Use by Wave 1 Past 30-day Cannabis Use Status Among Youth (PATH Wave 1, Ages 12–17)
| Past 30-day cannabis use at Wave 1 | Cannabis use versus no cannabis use | ||||||
|---|---|---|---|---|---|---|---|
| No cannabis use | Cannabis use | ||||||
| Past 30-day tobacco product use at Wave 1a | N b = 12 907 | %c | N b = 673 | %c | OR (95% CI) | aORd (95% CI) | aORe (95% CI) |
| Cigarette use (any use) | 369 | 2.8 | 255 | 37.1 | 20.5 (16.9, 24.8) | 13.4 (10.8, 16.6) | 11.9 (9.5, 14.9) |
| E-cigarette use (any use) | 262 | 2.1 | 152 | 22.7 | 13.9 (11.3, 17.2) | 9.0 (7.1, 11.4) | 7.4 (5.7, 9.6) |
| Dual product usef | 101 | 0.7 | 92 | 13.4 | 21.1 (15.8, 28.2) | 14.2 (10.1, 20.1) | 11.9 (8.2, 17.3) |
| Cigarette use (exclusive use) | 263 | 2.0 | 163 | 23.5 | 14.9 (12.0, 18.6) | 9.3 (7.2, 11.9) | 8.6 (6.6, 11.2) |
| E-cigarette use (exclusive use) | 160 | 1.3 | 60 | 9.3 | 7.7 (5.8, 10.1) | 4.7 (3.4, 6.5) | 3.9 (2.8, 5.5) |
Subgroup totals may not add up due to missing values (eg, dual product use + cigarette use [exclusive use] vs cigarette use [any use]). aOR = adjusted odds ratio; CI = confidence interval; OR = odds ratio; PATH = Population Assessment of Tobacco and Health Study.
a“Cigarette use (any use)” and “e-cigarette use (any use)” included all participants who reported cigarette or e-cigarette use, respectively (regardless of whether they reported use of the other product). “Cigarette use (exclusive use)” and “e-cigarette use (exclusive use)” included only participants who reported cigarette use and no e-cigarette use or participants who reported e-cigarette use and no cigarette use, respectively.
bUnweighted N.
cWeighted %.
dAdjusted for race, gender, and age.
eAdjusted for race, gender, age, past-month internalizing problems, and past-month externalizing problems.
fUse of both cigarettes and e-cigarettes in the past month.